Trail sensitivity in Ewing's sarcoma patients is modulated by the expression of death receptor 4 and its short isoform despite predominant dr5 level

MLA

Françoise Rédini, et al. “Trail Sensitivity in Ewing’s Sarcoma Patients Is Modulated by the Expression of Death Receptor 4 and Its Short Isoform despite Predominant Dr5 Level.” Bone, vol. 48, May 2011, p. S255. EBSCOhost, https://doi.org/10.1016/j.bone.2011.03.623.

APA

Françoise Rédini, Gaelle Picarda, Stéphane Téletchéa, Dominique Heymann, C. Pellat, Sylvanie Surget, Valérie Trichet, & Martine Berreur. (2011). Trail sensitivity in Ewing’s sarcoma patients is modulated by the expression of death receptor 4 and its short isoform despite predominant dr5 level. Bone, 48, S255. https://doi.org/10.1016/j.bone.2011.03.623

Chicago

Françoise Rédini, Gaelle Picarda, Stéphane Téletchéa, Dominique Heymann, C. Pellat, Sylvanie Surget, Valérie Trichet, and Martine Berreur. 2011. “Trail Sensitivity in Ewing’s Sarcoma Patients Is Modulated by the Expression of Death Receptor 4 and Its Short Isoform despite Predominant Dr5 Level.” Bone 48 (May): S255. doi:10.1016/j.bone.2011.03.623.